Evaluation of Polymicrobial Pulmonary Infections during Five Years at a Tertiary Hospital in Mashhad, Eastern Iran
,
Abstract
Background: Lung infection is a global health problem associated with high morbidity and mortality world-wide and increasing rates of hospitalization. Polymicrobial pleuropulmonary infection is define as the simultaneous isolations of two or more other organisms from lung secretions culture which are associated with increased infection severity outcome compared to monomicrobial Pleuropulmonary infections. The aim of this study is evaluation of polymicrobial pulmonary infection rate during March 2019 to February 2024 at a Tertiary Hospital in Mashhad, Eastern Iran.
Methods: This single-center retrospective study was conducted from March 2019 to February 2024 in Shahid Kamyab Hospital, Mashhad, Iran. Our data in this study included 429 patients with pulmonary infection in the five years studied, which 34 patients were under 18 years old and 395 patients were over 18 years old. The total number of positive lung samples of these patients was 532. In this study, we investigated the prevalence of polymicrobial lung infections along with the bacteria that cause them.
Results: A total of 532 positive lung culture specimens were included, which 196 cases were polymicrobial (36.8 %) and 336 cases were monomicrobial (63.2 %). this study showed that Acinetobacter baumannii had the most frequency among other bacteria which cause polymicrobial pulmonary infections (32 %).
Conclusion: Pulmonary infection is a serious complication, which significantly increases mortality rate and medical costs. In this retrospective study we have found that polymicrobial pulmonary infections in patients in this hospital was 36.8 % that Acinetobacter baumannii was the most cause of infections.
2. Frisan T. Co‐and polymicrobial infections in the gut mucosa: The host–microbiota–pathogen perspective. Cellular Microbiol 2021; 23(2): e13279.
3. Anju VT, Busi S, Imchen M. Polymicrobial Infections and Biofilms: Clinical significance and eradication strategies. Antibiotics 2022; 11(12):1731.
4. Cillóniz C., Civljak R, Nicolini A, et al. Polymicrobial community-acquired pneumonia: An emerging entity. Respirol 2016; 21(1):65-75.
5. Brogden KA, Guthmiller JM, Taylor CE. Human polymicrobial infections. Lancet 2005; 365(9455):253-5.
6. Mariani F, Galvan EM. Staphylococcus aureus in polymicrobial skinand soft tissue infections: Impact of Inter-Species Interactionsin Disease Outcome. Antibiotics 2023; 12(7):1164.
7. Tay WH, Chong KKL, Kline KA. Polymicrobial–host interactions during infection. J Mol Biol 2016; 428(17):3355-71.
8. Zhan D, Sun Y, He L, et al. Characteristics of the pulmonary microbiota in patients with mild and severe pulmonary infection. Front Cell Infect Microbiol 2023; 13: 1-10.
9. Rosati, L.A. and K.O. Leslie, 2017. Lung infections. Practical pulmonary pathology: a diagnostic approach, 3rd ed. Elsevier p. 137.
10. José RJ. Respiratory infections: a global burden. Annal Res Hospitals 2018; 2(9):3-6.
11. Pantanowitz L, Khalbuss WE, Laucirica R, et al. Pulmonary Infections. Cytopath Infect Dis 2011; 17(7):121-59.
12. Kradin RL. 2016 Understanding Pulmonary Pathology: Applying Pathological Findings in Therapeutic Decision Making. Academic Press; 1 st ed. Elsevier p. 157.
13. Hardak E, Berkun L, Lavi N, et al. Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection 2016; 44(4):491-7.
| Files | ||
| Issue | Vol 13 No 1 (2025) | |
| Section | Original Articles | |
| DOI | https://doi.org/10.18502/jmb.v13i1.18047 | |
| Keywords | ||
| Acinetobacter baumannii Infection Polymicrobial Pulmonary. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
